A DirEct to PatieNt Study in Chronic Pain
CompletedNCT05515341
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.
Study details
- Official title
- A DirEct to PatieNt Study in Chronic Pain
- Conditions
- Interventions
- Device: Commercially Approved Interventional Medical Device/Therapy for Chronic Pain
- Sponsor
- Boston Scientific Corporation
- Start date
- 2023-01-10
- Primary completion
- 2026-05-20
- Sex
- All
- Age range
- from 22 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: * Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting * Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening * Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English Key Exclusion Criteria: * Requires a legal representative to sign the ICF ascertained from self-reporting
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05515341